Segui
Joanne Clark
Joanne Clark
Email verificata su bham.ac.uk
Titolo
Citata da
Citata da
Anno
S100A8/A9 drives the formation of procoagulant platelets through GPIbα
M Colicchia, WC Schrottmaier, G Perrella, JS Reyat, J Begum, A Slater, ...
Blood, The Journal of the American Society of Hematology 140 (24), 2626-2643, 2022
522022
Targeting platelet GPVI with glenzocimab: a novel mechanism for inhibition
P Billiald, A Slater, M Welin, JC Clark, S Loyau, M Pugnière, IG Jiacomini, ...
Blood Advances 7 (7), 1258-1268, 2023
302023
Structural characterization of a novel GPVI-nanobody complex reveals a biologically active domain-swapped GPVI dimer
A Slater, Y Di, JC Clark, NJ Jooss, EM Martin, F Alenazy, MR Thomas, ...
Blood, The Journal of the American Society of Hematology 137 (24), 3443-3453, 2021
302021
Evidence that GPVI is expressed as a mixture of monomers and dimers, and that the D2 domain is not essential for GPVI activation
JC Clark, RAI Neagoe, M Zuidscherwoude, DM Kavanagh, A Slater, ...
Thrombosis and Haemostasis 121 (11), 1435-1447, 2021
272021
Adenosine and forskolin inhibit platelet aggregation by collagen but not the proximal signalling events
JC Clark, DM Kavanagh, S Watson, JA Pike, RK Andrews, EE Gardiner, ...
Thrombosis and Haemostasis 119 (07), 1124-1137, 2019
232019
Structure-function relationship of the platelet glycoprotein VI (GPVI) receptor: does it matter if it is a dimer or monomer?
JC Clark, FN Damaskinaki, YFH Cheung, A Slater, SP Watson
Platelets 32 (6), 724-732, 2021
202021
Experimental validation of computerised models of clustering of platelet glycoprotein receptors that signal via tandem SH2 domain proteins
Z Maqsood, JC Clark, EM Martin, YFH Cheung, LA Morán, SET Watson, ...
PLOS Computational Biology 18 (11), e1010708, 2022
82022
Katacine is a new ligand of CLEC-2 that acts as a platelet agonist
LA Morán, Y Di, MA Sowa, L Hermida-Nogueira, MN Barrachina, E Martin, ...
Thrombosis and haemostasis 122 (08), 1361-1368, 2022
82022
Divalent nanobodies to platelet CLEC-2 can serve as agonists or antagonists
JC Clark, EM Martin, LA Morán, Y Di, X Wang, M Zuidscherwoude, ...
Communications Biology 6 (1), 376, 2023
72023
Characterizing the binding of glycoprotein VI with nanobody 35 reveals a novel monomeric structure of glycoprotein VI where the conformation of D1+ D2 is independent of …
FN Damaskinaki, NJ Jooss, EM Martin, JC Clark, MR Thomas, NS Poulter, ...
Journal of Thrombosis and Haemostasis 21 (2), 317-328, 2023
52023
Trivalent nanobody-based ligands mediate powerful activation of GPVI, CLEC-2, and PEAR1 in human platelets whereas FcγRIIA requires a tetravalent ligand
EM Martin, JC Clark, SJ Montague, LA Morán, Y Di, LJ Bull, L Whittle, ...
Journal of Thrombosis and Haemostasis 22 (1), 271-285, 2024
32024
Corrigendum to ‘Trivalent nanobody-based ligands mediate powerful activation of GPVI, CLEC-2 and PEAR1 in human platelets whereas FcγRIIA requires a tetravalent ligand …
EM Martin, JC Clark, SJ Montague, LA Morán, Y Di, LJ Bull, L Whittle, ...
Journal of Thrombosis and Haemostasis 22 (8), 2378-2379, 2024
2024
PB0397 Differential Requirement for Ligand Valency in the Activation of CLEC-2 in Human and Humanised Mouse Platelets
J Clark, E Martin, L Moran, Y Di, H Brown, B Nieswandt, D Stegner, ...
Research and Practice in Thrombosis and Haemostasis 7, 2023
2023
Pharmacological Sciences OPEN ACCESS
JC Clark, SP Watson, DM Owen
Trends in Pharmacological Sciences 44 (10), 643, 2023
2023
Validation of agent-based models of surface receptor oligomerisation
JC Clark, SP Watson, DM Owen
Trends in Pharmacological Sciences, 2023
2023
The role of dimerisation in the activation of platelets by the collagen receptor GPVI
JC Clark
University of Birmingham, 2021
2021
This is a repository copy of Structural characterization of a novel GPVI-nanobody complex reveals a biologically active domain-swapped GPVI dimer.
A Slater, Y Di, JC Clark
2021
Targeting platelet GPVI with glenzocimab
P Billiald, A Slater, M Welin, J Clark, S Loyau, M Pugnière, IG Jiacomini, ...
Structure-function relationship of the platelet glycoprotein VI (GPVI) receptor
JC Clark, FN Damaskinaki, YFH Cheung, A Slater, SP Watson
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–19